youtu.be
La curiosidad hizo a THOMAS BESARME - #5 Evento Verano CDM New Gen 2026 Opal Lietch
YouTube video by Opal Lietch
#mcl is an active hashtag on Bluesky. In the last 30 days, 5 people shared 11 posts with it — around 0 a day. Activity is down 20% versus the previous week, peaking on Jul 27 with 2 posts.
Tags most often used together with #mcl.
youtu.be
La curiosidad hizo a THOMAS BESARME - #5 Evento Verano CDM New Gen 2026 Opal Lietch
YouTube video by Opal Lietch
youtu.be
La curiosidad hizo a THOMAS BESARME - #5 Evento Verano CDM New Gen 2026 Opal Lietch
YouTube video by Opal Lietch
youtu.be
La curiosidad hizo a THOMAS BESARME - #5 Evento Verano CDM New Gen 2026 Opal Lietch
YouTube video by Opal Lietch
youtu.be
La curiosidad hizo a THOMAS BESARME - #5 Evento Verano CDM New Gen 2026 Opal Lietch
YouTube video by Opal Lietch
youtu.be
Amanda me SALVA de los piratas - #4 Evento Verano CDM New Gen 2026 Opal Lietch
YouTube video by Opal Lietch
youtu.be
Amanda me SALVA de los piratas - #4 Evento Verano CDM New Gen 2026 Opal Lietch
YouTube video by Opal Lietch
youtu.be
JASON me CAPTURA en su barco - #2 Evento Verano CDM New Gen 2026 Opal Lietch
YouTube video by Opal Lietch
youtu.be
DEVON y yo: amor imposible siendo sirena - #2 Evento Verano CDM New Gen 2026 Opal Lietch
YouTube video by Opal Lietch
www.youtube.com
CSR News Bulletin: Karnataka CSR for Schools, MCL Road Project, Telangana Breakfast Scheme
YouTube video by Fiinovation
youtu.be
DEVON y yo: amor imposible siendo sirena - #2 Evento Verano CDM New Gen 2026 Opal Lietch
YouTube video by Opal Lietch
ascopubs.org
Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor
PURPOSEMantle cell lymphoma (MCL) is a rare and typically aggressive B-cell non-Hodgkin lymphoma characterized by recurrent relapse after short remissions. Sonrotoclax (BGB-11417) is a next-generation...
sohoinsider.com
China NMPA approves rocbrutinib for R/R MCL. - SOHO Insider
China's NMPA has granted accelerated approval to rocbrutinib in adult patients with relapsed or refractory mantle cell lymphoma.
Posts are pulled live from Bluesky and cached briefly. Posts with content labels are hidden.